Biomarker for Rapid Diagnosis of Hemispheric Stroke "BE FAST!"

Completed

Phase N/A Results N/A

Summary of Purpose

The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments [NR2-peptide] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 June 2011.

1 Jun 2009 9 Jun 2009 1 Jun 2011 1 Jun 2011 1 Jun 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts

Not available